tiprankstipranks
Can-Fite BioPharma (CANF)
XASE:CANF
US Market
CANF
Can-Fite BioPharma
RESEARCH TOOLSreports

Can-Fite BioPharma (CANF) Income Statement

652 Followers

Can-Fite BioPharma Income Statement

Last quarter (Q2 2025), Can-Fite BioPharma's total revenue was $101.00K, a decrease of -36.08% from the same quarter last year. In Q2, Can-Fite BioPharma's net income was $-2.44M. See Can-Fite BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 408.21K$ 674.00K$ 743.00K$ 810.00K$ 853.00K
Gross Profit
$ 384.02K$ 674.00K$ 743.00K$ 810.00K$ 853.00K
Operating Expenses
$ 10.41M$ 8.80M$ 8.94M$ 10.91M$ 13.70M
Depreciation and Amortization
$ 24.19K$ 7.00K$ 15.00K$ 14.00K$ 14.00K
EBITDA
$ -10.00M$ -8.12M$ -8.18M$ -10.08M$ -12.83M
Operating Income
$ -10.03M$ -8.13M$ -8.20M$ -10.10M$ -12.84M
Other Income/Expenses
$ 122.97K$ 250.00K$ 561.00K$ -77.00K$ 227.00K
Pretax Income
$ -9.91M$ -7.88M$ -7.63M$ -10.17M$ -12.62M
Net Income
$ -9.91M$ -7.88M$ -7.63M$ -10.17M$ -12.60M
Per Share Metrics
Basic EPS
$ -12.03$ -1.08$ -1.80$ -3.75$ -9.00
Diluted EPS
$ -12.03$ -1.08$ -1.80$ -3.75$ -8.25
Weighted Average Shares Outstanding
 823.93K 7.25M 4.26M 2.72M 1.53M
Weighted Average Shares Outstanding (Diluted)
 823.93K 7.25M 4.26M 2.72M 1.84M
Currency in USD

Can-Fite BioPharma Earnings and Revenue History